In vitro activity of garlic oil and four diallyl sulphides against antibiotic-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 47, Issue 5, 2001, Pages 665-670

  Tsao, Shyh Ming ^a   Yin, Mei Chin ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b Institute of Nutritional Science Chungshan Medical and Dental College   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYL SULFIDE; CEFTAZIDIME; DIALLYL DISULFIDE; DIALLYL TETRASULFIDE; DIALLYL TRISULFIDE; GARLIC OIL; GENTAMICIN; IMIPENEM; MEROPENEM; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; BACTERIUM ISOLATE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENTIATION; HOSPITAL INFECTION; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; TIME;

EID: 0035011923     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/47.5.665     Document Type: Article

References (23)

1. Chang, S. C., Hsieh, W. C. & Liu, C. (2000). High prevalence of antibiotic resistance of common pathogenic bacteria in Taiwan. The Antibiotics Resistance Study Group of the Infectious Disease Society of the Republic of China. Diagnostic Microbiology and Infectious Disease 36, 107-112.
2. Lu, C. H., Chang, W. N., Chuang, Y. C. & Chang, H. W. (1998). The prognostic factors of adult gram-negative bacillary meningitis. Journal of Hospital Infection 40, 27-34.
3. Ho, M., McDonald, L. C., Lauderdale, T. L., Yeh, L. L., Chen, P. C. & Shiau, Y. R. (1999). Surveillance of antibiotic resistance in Taiwan, 1998. Journal of Microbiology, Immunology and Infection 32, 239-49.
4. Caldwell, J. W., Singh, S. & Johnson, R. H. (1999). Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia. Journal of Antimicrobial Chemotherapy 43, Suppl. A, 129-34.
5. O'Gara, E. A., Hill, D. J. & Maslin, D. J. (2000). Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori. Applied Environmental Microbiology 66, 2269-73.
6. Pai, S. T. & Platt, M. W. (1995). Antifungal effects of Allium sativum (garlic) extract against the Aspergillus species involved in otomycosis. Letters in Applied Microbiology 20, 14-8.
7. Weber, N. D., Andersen, D. O., North, J. A., Murray, B. K., Lawson, L. D. & Hughes, B. G. (1992). In vitro virucidal effects of Allium sativum (garlic) extract and compounds. Planta Medica 58, 417-23.
8. Shoji, S., Furuishi, K., Yanase, R., Miyazaka, T. & Kino, M. (1993). Allyl compounds selectively killed human immunodeficiency virus (type 1)-infected cells. Biochemical and Biophysical Research Communications 194, 610-21.
9. Lawson, L. D., Wang, Z. Y. & Hughes, B. G. (1991). Identification and HPLC quantification of the sulfides and dialk(en)yl thiosulfinates in commercial garlic products. Planta Medica 57, 363-70.
10. Yoshida, S., Katsuzaki, H., Ohta, R., Ishikawa, K., Fukuda, H., Fujino, T. et al. (1999). An organosulfur compound isolated from oil-macerated garlic extract, and its antimicrobial effect. Bioscience Biotechnology and Biochemistry 63, 588-90.
11. Chen, G. W., Chung, J. G., Ho, H. C. & Lin, J. G. (1999). Effects of the garlic compounds diallyl sulphide and diallyl disulphide on arylamine N-acetyltransferase activity in Klebsiella pneumoniae. Journal of Applied Toxicology 19, 75-81.
12. Ravid, U. & Putievsky, E. (1985). Essential oils of Israeli wild species of Labiatae. In Essential Oils and Aromatic Plants, (Svendsen, B. & Scheffer, J. J. C., Eds), pp. 155-61, Martinus Nijhoff, Dordrecht, The Netherlands.
13. Sparnins, V. L., Barany, G. & Wattenberg, L. W. (1988). Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse. Carcinogenesis 9, 131-4.
14. National Committee for Clinical Laboratory Standards. (1999). Performance Standards for Antimicrobial Susceptibility Testing. Ninth Informational Supplement M100-S9. NCCLS, Villanova, PA.
15. National Committee for Clinical Laboratory Standards. (1997). Performance Standards for Checkerboard Synergy Tests. NCCLS, Villanova, PA.
16. Naganawa, R., Iwata, N., Ishikawa, K., Fukuda, H., Fujino, T. & Suzuki, A. (1996). Inhibition of microbial growth by ajoene, a sulfur-containing compound derived from garlic. Applied Environmental Microbiology 62, 4238-42.
17. Hsieh, S. E., Lo, H. H. & Chung, J. G. (1998). The characteristics of arylamine N-acetyltransferase in Pseudomonas aeruginosa. Current Microbiology 36, 353-60.
18. Lo, H. H., Hsieh, S. E., Tsai, K. J. & Chung, J. G. (1999). The effects of ellagic acid on arylamine N-acetyltransferase activity in the bacterium Pseudomonas aeruginosa. Drug and Chemical Toxicology 22, 555-62.
19. Matsumura, N., Minami, S., Watanabe, Y., Iyobe, S. & Mitsuhashi, S. (1999). Role of permeability in the activities of beta-lactams against gram-negative bacteria which produce a group 3 beta-lactamase. Antimicrobial Agents and Chemotherapy 43, 2084-6.
20. Farmer, T. H., Degnan, B. A. & Payne, D. J. (1999). Penetration of beta-lactamase inhibitors into the periplasm of gram-negative bacteria. FEMS Microbiology Letters 176, 11-5.
21. Curtis, N. A., Orr, D., Ross, G. W. & Boulton, M. G. (1979). Competition of beta-lactam antibiotics for the penicillin-binding proteins of Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella aerogenes, Proteus rettgeri, and Escherichia coli: comparison with antibacterial activity and effects upon bacterial morphology. Antimicrobial Agents and Chemotherapy 16, 325-8.
22. Delker, D. A., Papanikolaou, A., Suhr, Y. J. & Rosenberg, D. W. (2000), Diallyl sulfide enhances azoxymethane-induced preneoplasia in Fischer 344 rat colon. Chemico-Biological Interactions 124, 149-60.
23. Dragnev, K. H., Nims, R. W. & Lubet, R. A. (1995). The chemo-preventive agent diallyl sulfide. A structurally atypical phenobarbitaltype inducer. Biochemical Pharmacology 50, 2099-104.